Comparison of weekly docetaxel regimens in prostate cancer: a systematic review and frequentist network meta-analysis
Docetaxel dosing schedules show comparable PSA response rates. Triweekly dosing prolongs time to treatment failure but is associated with greater toxicity, whereas weekly dosing offers better tolerability. Treatment decisions should balance efficacy and safety based on individual patient characteristics.
Authors
- Waseef Ullah
- Fatima Sajjad (ORCID: https://orcid.org/0009-0009-8861-0367)
- Osama Ahmad
- Shree Rath
- Muzamil Khan (ORCID: https://orcid.org/0009-0005-6105-367X)
- Fareeda
- Umama Alam
- Ahmad Omar Saleh
- Amar Lal
- Z A R Y A B Bacha
- K Abdul Rehman
- Umair Hayat
Institutions
- University of Jordan (JO)
- Khyber Medical College (PK)
- George Washington University (US)
- CMH Lahore Medical College and Institute of Dentistry (PK)
- Lady Reading Hospital (PK)
- All India Institute of Medical Sciences Bhubaneswar (IN)
- National University of Medical Sciences (PK)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Exploration of Targeted Anti-tumor Therapy
- Published
- 2026-02-27
- DOI
- https://doi.org/10.37349/etat.2026.1002360
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00